The Hypothalamic Orexinergic System: Pain and Primary Headaches
暂无分享,去创建一个
[1] J. Olesen. The International Classification of Headache Disorders , 2008, Headache.
[2] F. Chollet,et al. Hypothalamic Activation in Spontaneous Migraine Attacks , 2007, Headache.
[3] J. V. Gerven,et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans , 2007, Nature Medicine.
[4] P. Goadsby,et al. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat , 2006, The European journal of neuroscience.
[5] Gerardo Rojas-Piloni,et al. Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist , 2006, PAIN.
[6] Richard S. J. Frackowiak,et al. Posterior hypothalamic activation in paroxysmal hemicrania , 2006, Annals of neurology.
[7] T. Yaksh. Central pharmacology of nociceptive transmission , 2006 .
[8] P. Goadsby,et al. Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception , 2005, Journal of Pharmacology and Experimental Therapeutics.
[9] T. Bartsch,et al. Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus , 2005, Pain.
[10] A. Ferguson,et al. Non-sleep effects of hypocretin/orexin. , 2005, Sleep medicine reviews.
[11] T. Sakurai. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. , 2005, Sleep medicine reviews.
[12] P. Goadsby,et al. Trigeminal autonomic cephalalgias. Pathophysiology and classification. , 2005, Revue neurologique.
[13] Richard R. Neubig,et al. International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.
[14] A. Deutch,et al. Dopaminergic regulation of orexin neurons , 2005, The European journal of neuroscience.
[15] O. Yuge,,et al. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats , 2005, Brain Research.
[16] Kazuhiro Takahashi,et al. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice , 2005, Peptides.
[17] T. Sakurai. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology , 2005, Regulatory Peptides.
[18] P. Goadsby,et al. Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[19] M. Yanagisawa,et al. Persistent pain and stress activate pain-inhibitory orexin pathways , 2005, Neuroreport.
[20] Karl J. Friston,et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. , 2004, Brain : a journal of neurology.
[21] Matharu,et al. Erratum: Subcutaneous octreotide in cluster headache: Randomized placebo-controlled double-blind crossover study (Annals of Neurology (October 2004) 56 (488-494)) , 2004 .
[22] L. Pinessi,et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache , 2004, Neurology.
[23] Satchidananda Panda,et al. It’s All in the Timing: Many Clocks, Many Outputs , 2004, Journal of biological rhythms.
[24] L. Kelman. The Premonitory Symptoms (Prodrome): A Tertiary Care Study of 893 Migraineurs , 2004, Headache.
[25] P. Goadsby,et al. Subcutaneous octreotide in cluster headache: Randomized placebo‐controlled double‐blind crossover study , 2004, Annals of neurology.
[26] Weontae Lee,et al. Solution structure of human orexin-A: regulator of appetite and wakefulness. , 2004, Journal of biochemistry and molecular biology.
[27] P. Erhard,et al. Hypothalamic Activation in Trigeminal Autonomic Cephalgia: Functional Imaging of an Atypical Case , 2004, Cephalalgia : an international journal of headache.
[28] H. Kaube,et al. Glyceryl trinitrate triggers premonitory symptoms in migraineurs , 2004, Pain.
[29] P. Goadsby,et al. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study , 2004, Neurobiology of Disease.
[30] C. Leonard,et al. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. , 2004, Journal of neurophysiology.
[31] T. Bartsch,et al. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area , 2004, Pain.
[32] H. Haas,et al. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons , 2004, The European journal of neuroscience.
[33] R. Lipton,et al. The epidemiology and impact of migraine , 2004, Current neurology and neuroscience reports.
[34] O. Yuge,,et al. Analgesic effect of intrathecal administration of orexin on neuropathic pain in rats. , 2004, In vivo.
[35] A. May,et al. Specific hypothalamic activation during a spontaneous cluster headache attack , 2004, Neurology.
[36] J. Siegel. Hypocretin (orexin): role in normal behavior and neuropathology. , 2004, Annual review of psychology.
[37] F. Morales,et al. Distribution of hypocretin (orexin) immunoreactivity in the feline pons and medulla , 2004, Brain Research.
[38] S. Datta. Cellular Basis of Pontine Ponto-geniculo-occipital Wave Generation and Modulation , 2004, Cellular and Molecular Neurobiology.
[39] Jes Olesen,et al. The International Classification of Headache Disorders: 2nd edition. , 2004, Cephalalgia : an international journal of headache.
[40] L. Hwang,et al. Antiallodynic Effects of Intrathecal Orexins in a Rat Model of Postoperative Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.
[41] O. Saito,et al. Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. , 2003, European journal of pharmacology.
[42] T. Chiba,et al. Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model , 2003, Neuroscience Letters.
[43] A. Ferguson,et al. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function , 2003, Frontiers in Neuroendocrinology.
[44] G. Broggi,et al. Hypothalamic deep brain stimulation for intractable chronic cluster headache: a 3-year follow-up , 2003, Neurological Sciences.
[45] D. Liebeskind,et al. Faces of the giant panda and her cub: MRI correlates of Wilson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[46] J. Parish,et al. Clinical, Anatomical, and Physiologic Relationship Between Sleep and Headache , 2003, Headache.
[47] N. Dahmen,et al. Increased Frequency of Migraine in Narcoleptic Patients: A Confirmatory Study , 2003, Cephalalgia : an international journal of headache.
[48] E. MacGregor,et al. Migraine Prevalence and Treatment Patterns: The Global Migraine and Zolmitriptan Evaluation Survey , 2003, Headache.
[49] Alec J Davidson,et al. SCN: ringmaster of the circadian circus or conductor of the circadian orchestra? , 2003, Novartis Foundation symposium.
[50] P. Ferroli,et al. STIMULATION OF THE POSTERIOR HYPOTHALAMUS FOR TREATMENT OF CHRONIC INTRACTABLE CLUSTER HEADACHES : FIRST REPORTED SERIES , 2003 .
[51] Sebastiaan Overeem,et al. The hypothalamus in episodic brain disorders , 2002, The Lancet Neurology.
[52] A. N. van den Pol,et al. Hypocretins (Orexins) Regulate Serotonin Neurons in the Dorsal Raphe Nucleus by Excitatory Direct and Inhibitory Indirect Actions , 2002, The Journal of Neuroscience.
[53] H. Haas,et al. Convergent Excitation of Dorsal Raphe Serotonin Neurons by Multiple Arousal Systems (Orexin/Hypocretin, Histamine and Noradrenaline) , 2002, The Journal of Neuroscience.
[54] T. Chiba,et al. Analgesic effect of intrathecally administered orexin‐A in the rat formalin test and in the rat hot plate test , 2002, British journal of pharmacology.
[55] O. Jöhren,et al. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus , 2002, Peptides.
[56] A. Yamatodani,et al. The effect of orexin-A and -B on the histamine release in the anterior hypothalamus in rats , 2002, Neuroscience Letters.
[57] G. Hervieu,et al. Protein distribution of the orexin-2 receptor in the rat central nervous system , 2002, Regulatory Peptides.
[58] H. Haas,et al. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro , 2002, Regulatory Peptides.
[59] T. Pringsheim. Cluster Headache: Evidence for a Disorder of Circadian Rhythm and Hypothalamic Function , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[60] R. Lipton,et al. Migraine--current understanding and treatment. , 2002, The New England journal of medicine.
[61] G. Hervieu,et al. Orexin receptor‐1 (OX‐R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake , 2002, The European journal of neuroscience.
[62] T. Kudo,et al. Orexin A and B evoke noradrenaline release from rat cerebrocortical slices , 2001, British journal of pharmacology.
[63] J L Go,et al. The trigeminal nerve. , 2001, Seminars in ultrasound, CT, and MR.
[64] S. Silberstein,et al. Hypothalamic involvement in chronic migraine , 2001, Journal of neurology, neurosurgery, and psychiatry.
[65] A Franzini,et al. Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. , 2001, The New England journal of medicine.
[66] M. Behbehani,et al. Physiological characteristics of the projection pathway from the medial preoptic to the nucleus raphe magnus of the rat and its modulation by the periaqueductal gray , 2001, PAIN.
[67] J. Holden,et al. Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by α1- and α2-adrenoceptors , 2001, Brain Research.
[68] C. Saper,et al. A neurohistochemical blueprint for pain-induced loss of appetite , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[69] K. Milenov,et al. Antinociceptive effect of somatostatin microinjected into caudate putamen , 2001, Peptides.
[70] C. Saper,et al. Differential expression of orexin receptors 1 and 2 in the rat brain , 2001, The Journal of comparative neurology.
[71] A. A. Parsons,et al. Orexin-A, an hypothalamic peptide with analgesic properties , 2001, Pain.
[72] J. Roberts,et al. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord , 2001, Neuroscience.
[73] R. Porter,et al. Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor. , 2001, Bioorganic & medicinal chemistry letters.
[74] H. Haas,et al. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat , 2001, Neuropharmacology.
[75] T. Okumura,et al. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. , 2001, Biochemical and biophysical research communications.
[76] O. Jöhren,et al. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. , 2001, Endocrinology.
[77] J. Holden,et al. Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors. , 2001, Brain research.
[78] C. Small,et al. Central Administration of Orexin A Suppresses Basal and Domperidone Stimulated Plasma Prolactin , 2000, Journal of neuroendocrinology.
[79] R S Frackowiak,et al. PET and MRA findings in cluster headache and MRA in experimental pain , 2000, Neurology.
[80] M. Parmentier,et al. The Orexin OX1 Receptor Activates a Novel Ca2+ Influx Pathway Necessary for Coupling to Phospholipase C* , 2000, The Journal of Biological Chemistry.
[81] Sebastiaan Overeem,et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.
[82] A. Beck‐Sickinger,et al. On the synthesis of orexin A: a novel one‐step procedure to obtain peptides with two intramolecular disulphide bonds , 2000, Journal of peptide science : an official publication of the European Peptide Society.
[83] M. Nakazato,et al. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord , 2000, Neuroscience Letters.
[84] A. Macgregor. Migraine associated with menstruation. , 2000, Functional neurology.
[85] C. V. van Eden,et al. The integration of stress by the hypothalamus, amygdala and prefrontal cortex: balance between the autonomic nervous system and the neuroendocrine system. , 2000, Progress in brain research.
[86] E. Bang,et al. Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B. , 1999, European journal of biochemistry.
[87] G. Aston-Jones,et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system , 1999, The Journal of comparative neurology.
[88] Shelagh Wilson,et al. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord☆ , 1999, Peptides.
[89] T. Horvath,et al. Brain Uncoupling Protein 2: Uncoupled Neuronal Mitochondria Predict Thermal Synapses in Homeostatic Centers , 1999, The Journal of Neuroscience.
[90] C. Büchel,et al. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: Short‐lasting neuralgiform headache with conjunctival injection and tearing , 1999, Annals of neurology.
[91] D. Smart. Orexins: a new family of neuropeptides. , 1999, British journal of anaesthesia.
[92] T. Sakurai,et al. Structure, tissue distribution, and pharmacological characterization of Xenopus orexins , 1999, Peptides.
[93] T. A. Harrison,et al. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla , 1999, Neuroscience Letters.
[94] M. Nakazato,et al. Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models , 1999, Neuroscience Letters.
[95] D. Middlemiss,et al. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell‐line using FLIPR , 1999, British journal of pharmacology.
[96] M. T. Shipley,et al. The organization of preoptic–medullary circuits in the male rat: evidence for interconnectivity of neural structures involved in reproductive behavior, antinociception and cardiovascular regulation , 1999, Neuroscience.
[97] Karl J. Friston,et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome , 1999, Nature Medicine.
[98] H. Romijn,et al. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway , 1999, The European journal of neuroscience.
[99] A. Pol. Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord , 1999 .
[100] J. Carroll,et al. Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on feed intake in young pigs. , 1999, Domestic animal endocrinology.
[101] N. Dahmen,et al. Increased frequency of migraine in narcoleptic patients , 1999, Neurology.
[102] M. Yanagisawa,et al. Widespread distribution of orexin in rat brain and its regulation upon fasting. , 1999, Biochemical and biophysical research communications.
[103] S. Schulz,et al. Selective targeting of somatostatin receptor 3 to neuronal cilia , 1999, Neuroscience.
[104] S. L. Dun,et al. Orexin A-like immunoreactivity in the rat brain , 1999, Neuroscience Letters.
[105] A. N. van den Pol,et al. Synaptic Interaction between Hypocretin (Orexin) and Neuropeptide Y Cells in the Rodent and Primate Hypothalamus: A Novel Circuit Implicated in Metabolic and Endocrine Regulations , 1999, The Journal of Neuroscience.
[106] M. Millan,et al. The induction of pain: an integrative review , 1999, Progress in Neurobiology.
[107] T. Sakurai,et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[108] A. N. van den Pol,et al. Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.
[109] D. Macneil,et al. Distribution of orexin receptor mRNA in the rat brain , 1998, FEBS letters.
[110] A. N. van den Pol,et al. Presynaptic and Postsynaptic Actions and Modulation of Neuroendocrine Neurons by a New Hypothalamic Peptide, Hypocretin/Orexin , 1998, The Journal of Neuroscience.
[111] Christian Büchel,et al. Hypothalamic activation in cluster headache attacks , 1998, The Lancet.
[112] P. Emson,et al. Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception , 1998, Brain Research.
[113] A. Fox,et al. Migraine Chronobiology , 1998, Headache.
[114] K. Franklin,et al. Morphine analgesia in the formalin test: reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray , 1998, Behavioural Brain Research.
[115] S. Carr,et al. Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.
[116] F E Bloom,et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[117] S. Carr,et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.
[118] N. Zurak. Role of the Suprachiasmatic Nucleus in the Pathogenesis of Migraine Attacks , 1997, Cephalalgia : an international journal of headache.
[119] B. Lumb,et al. Inhibitory effects evoked from the anterior hypothalamus are selective for the nociceptive responses of dorsal horn neurons with high- and low-threshold inputs. , 1997, Journal of neurophysiology.
[120] D. Bereiter. Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat , 1997, Neuroscience.
[121] E. Ovalı,et al. Treatment of Migraine Attacks with A Long-Acting Somatostatin Analogue (Octreotide, SMS 201-995) , 1997, Cephalalgia : an international journal of headache.
[122] R. Lipton,et al. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. , 1997, Brain : a journal of neurology.
[123] P. Emson,et al. Somatostatin receptors in the central nervous system , 1996, Progress in Neurobiology.
[124] J. Giesler. Evidence of direct nociceptive projections from the spinal cord to the hypothalamus and telencephalon , 1995 .
[125] J. Stamford. Descending control of pain. , 1995, British journal of anaesthesia.
[126] C. Weiller,et al. Brain stem activation in spontaneous human migraine attacks , 1995, Nature Medicine.
[127] J. Sandkühler,et al. Inhibition of spinal nociceptive neurons by microinjections of somatostatin into the nucleus raphe magnus and the midbrain periaqueductal gray of the anesthetized cat , 1995, Neuroscience Letters.
[128] A. Beaudet,et al. Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: relationship to neuroendocrine function , 1995, Neuroscience.
[129] W. Stewart,et al. Population variation in migraine prevalence: a meta-analysis. , 1995, Journal of clinical epidemiology.
[130] Y. Olsson,et al. Intrathecal and Epidural Somatostatin for Patients with Cancer: Analgesic Effects and Postmortem Neuropathologic Investigations of Spinal Cord and Nerve Roots , 1994, Anesthesiology.
[131] M. Quartu,et al. Somatostatin, galanin and peptide histidine isoleucine in the newborn and adult human trigeminal ganglion and spinal nucleus: Immunohistochemistry, neuronal morphometry and colocalization with substance P , 1994, Journal of Chemical Neuroanatomy.
[132] D. Hoyer,et al. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. , 1994, Digestion.
[133] H. Göbel,et al. [Migraine and tension headache. New procedures for objective differentiation]. , 1992, Fortschritte der Medizin.
[134] A. Dickenson,et al. The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord , 1992, Neuropeptides.
[135] J. Olesen,et al. Migraine With Aura and Migraine Without Aura: An Epidemiological Study , 1992, Cephalalgia : an international journal of headache.
[136] G. Solomon,et al. Circadian rhythms and migraine. , 1992, Cleveland Clinic journal of medicine.
[137] N. Breslau,et al. Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults , 1991, Psychiatry Research.
[138] J. Olesen,et al. Epidemiology of headache in a general population--a prevalence study. , 1991, Journal of clinical epidemiology.
[139] B. Lumb. Hypothalamic influences on viscero‐somatic neurones in the lower thoracic spinal cord of the anaesthetized rat. , 1990, The Journal of physiology.
[140] N. Lazarov,et al. Localization of somatostatin-like immunoreactive fibres in the trigeminal principal sensory nucleus of the cat. , 1990, Acta histochemica.
[141] E. Carstens,et al. Medial hypothalamic stimulation suppresses nociceptive spinal dorsal horn neurons but not the tail-flick reflex in the rat , 1988, Brain Research.
[142] N. Raskin,et al. Headache May Arise From Perturbation of Brain , 1987, Headache.
[143] E. Carstens. Hypothalamic inhibition of rat dorsal horn neuronal responses to noxious skin heating , 1986, Pain.
[144] J. Chrubasik,et al. The Effect of Epidural Somatostatin on Postoperative Pain , 1985, Anesthesia and analgesia.
[145] M. Moskowitz. The neurobiology of vascular head pain , 1984, Annals of neurology.
[146] R. Przewłocki,et al. Evidence for a role of the ventro-medial posterior hypothalamus in nociceptive processes in the rat , 1983, Pharmacology Biochemistry and Behavior.
[147] Moore Ry. Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus. , 1983 .
[148] E. Carstens,et al. Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by lateral hypothalamic stimulation in the cat. , 1983, Journal of neurophysiology.
[149] R. Moore. Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus. , 1983, Federation proceedings.
[150] E. Carstens,et al. Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by medial hypothalamic stimulation in the cat. , 1982, Journal of neurophysiology.
[151] M. Randić,et al. The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: an intracellular study , 1982, Brain Research.
[152] H. J. Gamble. The Human Nervous System. An Anatomical Viewpoint , 1980 .
[153] M. Randić,et al. Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli , 1978, Brain Research.
[154] W. R. Ingram. THE HYPOTHALAMUS , 1938, Ciba clinical symposia.
[155] J. Turner. ANATOMY OF THE CENTRAL NERVOUS SYSTEM , 1955 .
[156] H. Wolff,et al. EXPERIMENTAL STUDIES ON HEADACHE , 1942 .
[157] H. Wolff,et al. EXPERIMENTAL STUDIES ON HEADACHE: PAIN-SENSITIVE STRUCTURES OF THE HEAD AND THEIR SIGNIFICANCE IN HEADACHE , 1940 .